A novel approach to label bone marrow-derived mesenchymal stem cells with mixed-surface PAMAM dendrimers
Abstract Background Transplantation of mesenchymal stem cells has created enormous opportunities as a potential treatment for various diseases including neurodegenerative diseases. Given current techniques, such as Hoechst labeling, have safety and leakage issues, our study focused, as a proof-of-co...
Main Authors: | Nikolas Munro, Bhairavi Srinageshwar, Firas Shalabi, Maria Florendo, Paulina Otero, Cassandra Thompson, Jordyn Kippe, Clayton Malkowski, Sydney Climie, Andrew N. Stewart, Rachel Kim, Joseph Zhou, Douglas Swanson, Gary L. Dunbar, Ajit Sharma, Julien Rossignol |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2019-02-01
|
Series: | Stem Cell Research & Therapy |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s13287-019-1171-7 |
Similar Items
-
PAMAM Dendrimer Nanomolecules Utilized as Drug Delivery Systems for Potential Treatment of Glioblastoma: A Systematic Review
by: Fana M, et al.
Published: (2020-04-01) -
Use of Polyamidoamine Dendrimers in Brain Diseases
by: Maria Florendo, et al.
Published: (2018-09-01) -
High Fluorescent Porphyrin-PAMAM-Fluorene Dendrimers
by: Karla I. Garfias-Gonzalez, et al.
Published: (2015-05-01) -
In Vitro Evaluation of Third Generation PAMAM Dendrimer Conjugates
by: Mohammad Najlah, et al.
Published: (2017-10-01) -
PAMAM Dendrimers Cross the Blood–Brain Barrier When Administered through the Carotid Artery in C57BL/6J Mice
by: Bhairavi Srinageshwar, et al.
Published: (2017-03-01)